{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:44:13Z","timestamp":1790419453210,"version":"4.1.0"},"reference-count":124,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Medication overuse headache (MOH), new daily persistent headache (NDPH), and persistent refractory headache attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection represent a significant burden in terms of disability and quality of life, and a challenge in terms of definition, pathophysiology, and treatment. Regarding MOH, prevention without withdrawal is not inferior to prevention with withdrawal. Preventive medications like topiramate, onabotulinumtoxinA, and calcitonin gene-related peptide (CGRP) monoclonal antibodies improve chronic migraine with MOH regardless of withdrawal. The differential diagnosis of NDPH is broad and should be carefully examined. There are no guidelines for the treatment of NDPH, but options include a short course of steroids, nerve blocks, topiramate, nortriptyline, gabapentin, CGRP monoclonal antibodies, and onabotulinumtoxinA. The persistence of headache 3 months after SARS-CoV2 infection is a predictor of poor prognosis.<\/jats:p>","DOI":"10.1055\/s-0042-1757925","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T23:37:37Z","timestamp":1667432257000},"page":"512-522","source":"Crossref","is-referenced-by-count":3,"title":["Refractory Headaches"],"prefix":"10.1055","volume":"42","author":[{"given":"Olivia","family":"Begasse de Dhaem","sequence":"additional","affiliation":[{"name":"Headache Specialist at Hartford HealthCare, Hartford, Connecticut"},{"name":"Department of Neurology at the University of Connecticut, Milford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-3110","authenticated-orcid":false,"given":"Paul","family":"Rizzoli","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women's Faulkner Hospital J Graham Headache Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(10)70008-9","article-title":"Clinical features, pathophysiology, and treatment of medication-overuse headache","volume":"9","author":"S Evers","year":"2010","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s10194-019-1022-z","article-title":"New daily persistent headache: a systematic review on an enigmatic disorder","volume":"20","author":"N Yamani","year":"2019","journal-title":"J Headache Pain"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0333102420920644","article-title":"Clinic-based characterization of continuous headache in children and adolescents: comparing youth with chronic migraine to those with new daily persistent headache","volume":"40","author":"B L Reidy","year":"2020","journal-title":"Cephalalgia"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"e1409","DOI":"10.1212\/WNL.0000000000200117","article-title":"Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized, pragmatic clinical trial","volume":"98","author":"T J Schwedt","year":"2022","journal-title":"Neurology"},{"issue":"01","key":"ref5","first-page":"1","article-title":"The International Classification of Headache Disorders. 3rd ed","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1129-2377-15-47","article-title":"Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation","volume":"15","author":"P Martelletti","year":"2014","journal-title":"J Headache Pain"},{"issue":"09","key":"ref7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1468-2982.2006.01173.x","article-title":"Towards a definition of intractable headache for use in clinical practice and trials","volume":"26","author":"P J Goadsby","year":"2006","journal-title":"Cephalalgia"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1526-4610.2008.01132.x","article-title":"Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society","volume":"48","author":"E A Schulman","year":"2008","journal-title":"Headache"},{"issue":"S 01","key":"ref9","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s10072-008-0888-3","article-title":"When should \u201cchronic migraine\u201d patients be considered \u201crefractory\u201d to pharmacological prophylaxis?","volume":"29","author":"D D'Amico","year":"2008","journal-title":"Neurol Sci"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s10194-020-01130-5","article-title":"European headache federation consensus on the definition of resistant and refractory migraine: developed with the endorsement of the European Migraine & Headache Alliance (EMHA)","volume":"21","author":"S Sacco","year":"2020","journal-title":"J Headache Pain"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: risk factors, pathophysiology and management","volume":"12","author":"H C Diener","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs","volume":"59","author":"V Limmroth","year":"2002","journal-title":"Neurology"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/brain\/awaa211","article-title":"Differential medication overuse risk of novel anti-migraine therapeutics","volume":"143","author":"C Saengjaroentham","year":"2020","journal-title":"Brain"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0333102410387678","article-title":"Medication adaptation headache","volume":"31","author":"M Solomon","year":"2011","journal-title":"Cephalalgia"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/WNL.0000000000004371","article-title":"Medication overuse headache: an entrenched idea in need of scrutiny","volume":"89","author":"A I Scher","year":"2017","journal-title":"Neurology"},{"key":"ref16","volume-title":"15. Chronic Migraine and Medication Overuse","author":"P B Rizzoli","year":"2022"},{"key":"ref17","first-page":"159","volume-title":"Migraine treatment as a cause of chronic migraine","author":"H Isler","year":"1982"},{"key":"ref18","first-page":"335","article-title":"Paradoxical effects of frequent analgesic use","volume":"33","author":"L Kudrow","year":"1982","journal-title":"Adv Neurol"},{"issue":"09","key":"ref19","first-page":"153","article-title":"Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects","volume":"26","author":"G A Peters","year":"1951","journal-title":"Proc Staff Meet Mayo Clin"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"M E Bigal","year":"2008","journal-title":"Headache"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/head.12201","article-title":"Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study","volume":"53","author":"R B Lipton","year":"2013","journal-title":"Headache"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/01.WNL.0000113747.18760.D2","article-title":"Incidence and predictors for chronicity of headache in patients with episodic migraine","volume":"62","author":"Z Katsarava","year":"2004","journal-title":"Neurology"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/01.WNL.0000069924.69078.8D","article-title":"Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study","volume":"61","author":"J A Zwart","year":"2003","journal-title":"Neurology"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0333102415593088","article-title":"Treatment of medication-overuse headache: a systematic review","volume":"36","author":"C C Chiang","year":"2016","journal-title":"Cephalalgia"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0333102419876907","article-title":"Medication overuse headache: the trouble with prevalence estimates","volume":"40","author":"E W Loder","year":"2020","journal-title":"Cephalalgia"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1468-2982.2009.01906.x","article-title":"Prevalence of chronic migraine and medication overuse headache in Germany\u2014the German DMKG headache study","volume":"30","author":"A Straube","year":"2010","journal-title":"Cephalalgia"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/01.WNL.0000120545.45443.93","article-title":"Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life","volume":"62","author":"R Col\u00e1s","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1468-2982.2008.01737.x","article-title":"How clinicians can detect, prevent and treat medication overuse headache","volume":"28","author":"D W Dodick","year":"2008","journal-title":"Cephalalgia"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1468-2982.2006.01211.x","article-title":"Chronic frequent headache in the general population: comorbidity and quality of life","volume":"26","author":"N J Wiendels","year":"2006","journal-title":"Cephalalgia"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1468-2982.2002.00413.x","article-title":"Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway","volume":"22","author":"K Hagen","year":"2002","journal-title":"Cephalalgia"},{"issue":"07","key":"ref31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1526-4610.2009.01457.x","article-title":"Obsessive-compulsive disorder and migraine with medication-overuse headache","volume":"49","author":"L M Cupini","year":"2009","journal-title":"Headache"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1468-2982.2005.00910.x","article-title":"Psychiatric comorbidity in the evolution from migraine to medication overuse headache","volume":"25","author":"F Radat","year":"2005","journal-title":"Cephalalgia"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpain.2004.07.006","article-title":"Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache","volume":"9","author":"H T Atasoy","year":"2005","journal-title":"Eur J Pain"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1526-4610.2009.01591.x","article-title":"Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache","volume":"50","author":"W Supornsilpchai","year":"2010","journal-title":"Headache"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-021-00818-9","article-title":"The evolution of medication overuse headache: history, pathophysiology and clinical update","volume":"35","author":"C Sun-Edelstein","year":"2021","journal-title":"CNS Drugs"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1526-4637.2011.01183.x","article-title":"Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study","volume":"13","author":"S Ferraro","year":"2012","journal-title":"Pain Med"},{"issue":"39","key":"ref37","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1523\/JNEUROSCI.3804-12.2013","article-title":"Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex","volume":"33","author":"F Riederer","year":"2013","journal-title":"J Neurosci"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0333102414521508","article-title":"A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study","volume":"34","author":"C Tassorelli","year":"2014","journal-title":"Cephalalgia"},{"issue":"08","key":"ref39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(04)00824-5","article-title":"Medication-overuse headache: a worldwide problem","volume":"3","author":"H C Diener","year":"2004","journal-title":"Lancet Neurol"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0333102412462638","article-title":"Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study","volume":"33","author":"K Rabe","year":"2013","journal-title":"Cephalalgia"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.wnl.0000263652.46222.e8","article-title":"Prednisolone does not reduce withdrawal headache: a randomized, double-blind study","volume":"69","author":"M G B\u00f8e","year":"2007","journal-title":"Neurology"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","article-title":"Reduction in medication-overuse headache after short information. The Akershus study of chronic headache","volume":"18","author":"R B Grande","year":"2011","journal-title":"Eur J Neurol"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00415-015-7975-1","article-title":"Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial","volume":"263","author":"E S Kristoffersen","year":"2016","journal-title":"J Neurol"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1468-1331.2010.03157.x","article-title":"Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache","volume":"18","author":"P Rossi","year":"2011","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/head.13194","article-title":"Headache education active-waiting directive: a program to enhance well-being during long referral wait times","volume":"58","author":"A M Lagman-Bartolome","year":"2018","journal-title":"Headache"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial","volume":"77","author":"L N Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"issue":"07","key":"ref47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/03331024211067791","article-title":"Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache","volume":"42","author":"U Pensato","year":"2022","journal-title":"Cephalalgia"},{"issue":"20","key":"ref48","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial","volume":"92","author":"S J Tepper","year":"2019","journal-title":"Neurology"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study","volume":"21","author":"S D Silberstein","year":"2020","journal-title":"J Headache Pain"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0333102420966658","article-title":"Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine","volume":"41","author":"D W Dodick","year":"2021","journal-title":"Cephalalgia"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/head.14036","article-title":"Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: subgroup analysis of PROMISE-2","volume":"61","author":"H C Diener","year":"2021","journal-title":"Headache"},{"issue":"09","key":"ref52","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/head.14206","article-title":"Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache","volume":"61","author":"M J Marmura","year":"2021","journal-title":"Headache"},{"issue":"09","key":"ref53","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/head.13385","article-title":"A qualitative study on patients with chronic migraine with medication overuse headache: comparing frequent and non-frequent relapsers","volume":"58","author":"C Scaratti","year":"2018","journal-title":"Headache"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ncl.2019.07.003","article-title":"Behavioral interventions for migraine","volume":"37","author":"A P\u00e9rez-Mu\u00f1oz","year":"2019","journal-title":"Neurol Clin"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1468-2982.2008.01717.x","article-title":"Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study","volume":"29","author":"M Altieri","year":"2009","journal-title":"Cephalalgia"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s10194-017-0728-z","article-title":"Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: an effectiveness trial with a one-year follow-up","volume":"18","author":"L Grazzi","year":"2017","journal-title":"J Headache Pain"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10072-021-05836-5","article-title":"Management of chronic migraine with medication overuse by web-based behavioral program during the COVID-19 emergency: results at 12 months","volume":"43","author":"L Grazzi","year":"2022","journal-title":"Neurol Sci"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1526-4610.2011.01872.x","article-title":"New daily persistent headache: a syndrome, not a discrete disorder","volume":"51","author":"P J Goadsby","year":"2011","journal-title":"Headache"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1526-4610.2012.02280.x","article-title":"The heterogeneity of new daily persistent headache","volume":"52","author":"M S Robbins","year":"2012","journal-title":"Headache"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10194-011-0346-0","article-title":"Post-infectious headache: a reactive headache?","volume":"12","author":"S Prakash","year":"2011","journal-title":"J Headache Pain"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1526-4610.1999.3902132.x","article-title":"Postmeningitis headache","volume":"39","author":"M Y Neufeld","year":"1999","journal-title":"Headache"},{"key":"ref62","first-page":"1","article-title":"P-05 Nutcracker phenomenon with headache as the predominant symptom: A unique new daily persistent headache subtype? 63rd Annual Scientific Meeting American Headache Society\u00ae","volume":"61","author":"T Rozen","year":"2021","journal-title":"Headache"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1212\/WNL.0000000000008707","article-title":"Clinical Reasoning: An underrecognized etiology of new daily persistent headache","volume":"94","author":"J R Duvall","year":"2020","journal-title":"Neurology"},{"issue":"05","key":"ref64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10194-007-0418-3","article-title":"The differential diagnosis of chronic daily headaches: an algorithm-based approach","volume":"8","author":"M E Bigal","year":"2007","journal-title":"J Headache Pain"},{"issue":"05","key":"ref65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-019-0936-9","article-title":"New daily persistent headache: a diagnostic and therapeutic odyssey","volume":"19","author":"E J Riddle","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"17","key":"ref66","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0b013e3181dad5de","article-title":"Clinical and prognostic subforms of new daily-persistent headache","volume":"74","author":"M S Robbins","year":"2010","journal-title":"Neurology"},{"issue":"02","key":"ref67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pediatrneurol.2004.02.006","article-title":"What incites new daily persistent headache in children?","volume":"31","author":"K J Mack","year":"2004","journal-title":"Pediatr Neurol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1468-2982.2002.00326.x","article-title":"The clinical characteristics of new daily persistent headache","volume":"22","author":"D Li","year":"2002","journal-title":"Cephalalgia"},{"issue":"S 02","key":"ref69","first-page":"ii6","article-title":"New daily persistent headache","volume":"72","author":"P J Goadsby","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11910-004-0025-5","article-title":"Spontaneous low cerebrospinal pressure\/volume headaches","volume":"4","author":"B Mokri","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"08","key":"ref71","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/head.13624","article-title":"The three T's of NDPH (how clinical observations have led to improved treatment outcomes)","volume":"59","author":"T D Rozen","year":"2019","journal-title":"Headache"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1129-2377-14-100","article-title":"New daily persistent headache with a thunderclap headache onset and complete response to nimodipine (a new distinct subtype of NDPH)","volume":"14","author":"T D Rozen","year":"2013","journal-title":"J Headache Pain"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/head.13495","article-title":"An RCVS spectrum disorder? New daily persistent headache starting as a single thunderclap headache (3 new cases)","volume":"59","author":"S A Jamali","year":"2019","journal-title":"Headache"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10194-021-01223-9","article-title":"Post-reversible cerebral vasoconstriction syndrome headache","volume":"22","author":"Y H Ling","year":"2021","journal-title":"J Headache Pain"},{"issue":"07","key":"ref77","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0883073815624761","article-title":"New daily persistent headache is most likely to begin at the start of school","volume":"31","author":"L R Grengs","year":"2016","journal-title":"J Child Neurol"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/diagnostics11030385","article-title":"Features and management of new daily persistent headache in developmental-age patients","volume":"11","author":"L Papetti","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ejp.1000","article-title":"Psychiatric comorbidity in new daily persistent headache: a cross-sectional study","volume":"21","author":"R Uniyal","year":"2017","journal-title":"Eur J Pain"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/head.13712","article-title":"the day my life changed: a qualitative study of the experiences of patients with new daily persistent headache","volume":"60","author":"D Palacios-Ce\u00f1a","year":"2020","journal-title":"Headache"},{"issue":"11","key":"ref81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1468-2982.2009.01842.x","article-title":"Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache","volume":"29","author":"R B Grande","year":"2009","journal-title":"Cephalalgia"},{"issue":"03","key":"ref82","first-page":"190","article-title":"Kaplan Award 1998. Epidemiology of chronic daily headache in the general population","volume":"39","author":"J Castillo","year":"1999","journal-title":"Headache"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11916-022-01005-1","article-title":"Update of New Daily Persistent Headache","volume":"26","author":"K P Peng","year":"2022","journal-title":"Curr Pain Headache Rep"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(87)90119-X","article-title":"Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches","volume":"1","author":"F Diaz-Mitoma","year":"1987","journal-title":"Lancet"},{"issue":"S 03","key":"ref85","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1007\/s10072-004-0310-8","article-title":"New daily persistent headache: clinical and serological characteristics in a retrospective study","volume":"25","author":"P Meineri","year":"2004","journal-title":"Neurol Sci"},{"issue":"10","key":"ref86","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1468-2982.2006.01187.x","article-title":"Cervical spine joint hypermobility: a possible predisposing factor for new daily persistent headache","volume":"26","author":"T D Rozen","year":"2006","journal-title":"Cephalalgia"},{"issue":"S 03","key":"ref87","first-page":"A419","article-title":"A consecutive series of ten cases of new daily persistent headache: clinical presentation and morphology of the venous system","volume":"72","author":"A Donnet","year":"2009","journal-title":"Neurology"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3345\/kjp.2015.58.2.73","article-title":"New daily persistent headache with isolated sphenoiditis in children","volume":"58","author":"J Lee","year":"2015","journal-title":"Korean J Pediatr"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/head.12707","article-title":"Triggering events and new daily persistent headache: age and gender differences and insights on pathogenesis\u2014a clinic-based study","volume":"56","author":"T D Rozen","year":"2016","journal-title":"Headache"},{"issue":"10","key":"ref90","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s10072-021-05444-3","article-title":"New daily persistent headache after SARS-CoV-2 infection: a report of two cases","volume":"42","author":"F Dono","year":"2021","journal-title":"Neurol Sci"},{"issue":"13","key":"ref91","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/0333102420965157","article-title":"Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution","volume":"40","author":"E Caronna","year":"2020","journal-title":"Cephalalgia"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/head.13011","article-title":"New daily persistent headache caused by a multinodular goiter and headaches associated with thyroid disease","volume":"57","author":"R W Evans","year":"2017","journal-title":"Headache"},{"issue":"09","key":"ref93","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/head.13655","article-title":"New daily persistent headache syndrome secondary to clival metastasis within an osseous hemangioma","volume":"59","author":"O Ogunlaja","year":"2019","journal-title":"Headache"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/08830738060210050601","article-title":"Meningismus is a commonly overlooked finding in tension-type headache in children and adolescents","volume":"21","author":"I Almazov","year":"2006","journal-title":"J Child Neurol"},{"issue":"07","key":"ref95","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1526-4610.2006.00722.x","article-title":"Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine","volume":"47","author":"T Rozen","year":"2007","journal-title":"Headache"},{"issue":"06","key":"ref96","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10194-012-0461-6","article-title":"Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India","volume":"13","author":"S Prakash","year":"2012","journal-title":"J Headache Pain"},{"issue":"15","key":"ref97","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0333102411424620","article-title":"New daily persistent headache: should migrainous features be incorporated?","volume":"31","author":"K P Peng","year":"2011","journal-title":"Cephalalgia"},{"issue":"05","key":"ref98","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11940-002-0050-0","article-title":"Migraine headache: immunosuppressant therapy","volume":"4","author":"T D Rozen","year":"2002","journal-title":"Curr Treat Options Neurol"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s10194-018-0835-5","article-title":"Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation","volume":"19","author":"F Puledda","year":"2018","journal-title":"J Headache Pain"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/head.12992","article-title":"Peripheral nerve blocks for the treatment of headache in older adults: a retrospective study","volume":"57","author":"J R Hascalovici","year":"2017","journal-title":"Headache"},{"issue":"02","key":"ref101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2013.09.008","article-title":"Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders","volume":"50","author":"A A Gelfand","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"12","key":"ref102","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1177\/0333102419848121","article-title":"Multiple cranial nerve blocks for the transitional treatment of chronic headaches","volume":"39","author":"S Miller","year":"2019","journal-title":"Cephalalgia"},{"issue":"07","key":"ref103","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11916-014-0431-6","article-title":"New daily persistent headache: an update","volume":"18","author":"T D Rozen","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"ref104","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/head.12987","article-title":"Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study","volume":"56","author":"L Doyle Strauss","year":"2016","journal-title":"Headache"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2020.09.014","article-title":"Calcitonin gene-related peptide monoclonal antibody use for the preventive treatment of refractory headache disorders in adolescents","volume":"114","author":"K A Greene","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s10194-021-01323-6","article-title":"CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience","volume":"22","author":"A Scheffler","year":"2021","journal-title":"J Headache Pain"},{"issue":"06","key":"ref107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10194-008-0078-y","article-title":"Efficacy of botulinum toxin type A in new daily persistent headache","volume":"9","author":"R C Spears","year":"2008","journal-title":"J Headache Pain"},{"issue":"S 01","key":"ref108","doi-asserted-by":"crossref","first-page":"A119","DOI":"10.1186\/1129-2377-16-S1-A119","article-title":"P009. A case of new daily persistent headache treated with botulinum toxin type A","volume":"16","author":"M Trucco","year":"2015","journal-title":"J Headache Pain"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11910-013-0425-5","article-title":"New daily persistent headache and potential new therapeutic agents","volume":"14","author":"S G Joshi","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0000000000000313","article-title":"New daily persistent headache and onabotulinumtoxin A therapy","volume":"42","author":"A Ali","year":"2019","journal-title":"Clin Neuropharmacol"},{"key":"ref111","first-page":"S49","article-title":"Rozen: doxycycline for treatment resistant new daily... - Google Scholar","volume":"48","author":"T D Rozen","year":"2008","journal-title":"Headache"},{"key":"ref113","first-page":"2050313","article-title":"Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine","volume":"7","author":"Z Tariq","year":"2019","journal-title":"SAGE Open Med Case Rep"},{"issue":"02","key":"ref114","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2008.01281.x","article-title":"Intravenous lidocaine in the treatment of refractory headache: a retrospective case series","volume":"49","author":"N Rosen","year":"2009","journal-title":"Headache"},{"issue":"02","key":"ref116","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/head.13013","article-title":"Ketamine infusions for treatment refractory headache","volume":"57","author":"J L Pomeroy","year":"2017","journal-title":"Headache"},{"issue":"10","key":"ref117","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1526-4610.2008.01234.x","article-title":"Mexiletine for refractory chronic daily headache: a report of nine cases","volume":"48","author":"M J Marmura","year":"2008","journal-title":"Headache"},{"issue":"06","key":"ref118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ner.13282","article-title":"Long-term outcomes of occipital nerve stimulation for new daily persistent headache with migrainous features","volume":"24","author":"S Lagrata","year":"2021","journal-title":"Neuromodulation"},{"issue":"20","key":"ref119","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","article-title":"Intravenous dihydroergotamine for inpatient management of refractory primary headaches","volume":"77","author":"A J Nagy","year":"2011","journal-title":"Neurology"},{"issue":"08","key":"ref120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/03331024211068074","article-title":"Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients","volume":"42","author":"D Garcia-Azorin","year":"2022","journal-title":"Cephalalgia"},{"issue":"01","key":"ref122","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: a systematic review and meta-analysis","volume":"11","author":"S Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"C Huang","year":"2021","journal-title":"Lancet"},{"issue":"02","key":"ref124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/03331024211036665","article-title":"Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19","volume":"42","author":"K Messlinger","year":"2022","journal-title":"Cephalalgia"},{"issue":"13","key":"ref125","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/0333102418771350","article-title":"Current understanding of meningeal and cerebral vascular function underlying migraine headache","volume":"39","author":"D Levy","year":"2019","journal-title":"Cephalalgia"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-021-02229-5","article-title":"Headache and immunological\/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms","volume":"18","author":"L Biscetti","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"06","key":"ref127","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"M Boldrini","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"ref128","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"J Matschke","year":"2020","journal-title":"Lancet Neurol"},{"issue":"09","key":"ref129","first-page":"628","article-title":"Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group","volume":"35","author":"N Moroll\u00f3n","year":"2020","journal-title":"Neurologia (Engl Ed)"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1757925.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T23:49:43Z","timestamp":1667432983000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1757925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":124,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2022,11,2]]},"published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1757925","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}